•  
  •  
 

Author Credentials

Abhinav Sharma, MBBS, Carolina de Elia, MD, Eric Arguelles, MD, Christine L. Gilkerson, MD

DOI

http://dx.doi.org/10.18590/mjm.2016.vol2.iss4.7

Abstract

Atypical hemolytic syndrome is an extremely rare, life threatening, progressive disease. Approximately one to two cases per million are seen annually in the US (3,4). It is known to be associated with variety of conditions including infections, drugs, autoimmune conditions, vaccination, malignancy, organ transplantation, pregnancy, and metabolic conditions (11,13).We hereby describe a case of atypical hemolytic uremic syndrome associated with CABG surgery. A 58 year old female presented to the emergency department (ED) with three days of worsening shortness of breath and cold like symptoms including nausea, vomiting and rhinorrhea. Twenty six days prior to presentation she had undergone Coronary Artery Bypass Graft (CABG) for three vessel disease. The physical examination was unremarkable. Labs showed anemia, acute renal injury and thrombocytopenia. A peripheral smear demonstrated over 10 per high-power field of schistocytes. She was presumptively diagnosed with Thrombotic Thrombocytopenic Purpura (TTP) and started on plasmapheresis. ADAMSTS-13 was normal and autoimmune workup was negative. After an extensive workup she was diagnosed with Atypical Hemolytic Uremic Syndrome (aHUS). To our knowledge this is the first case of aHUS associated with CABG. In fact, there has been only one other case of aHUS related to cardiac surgery which was found in a child who underwent Tetralogy of Fallot repair (1).

Key Words:

Atypical hemolytic uremic syndrome, CABG, TTP, Acute renal failure, Thrombocytopenia

Conflict(s) of Interest

N/A

References with DOI

1.Matsukuma E, Imamura A, Iwata Y, Takeuchi T, Yoshida Y, Fujimura Y, et al. Postoperative atypical hemolytic uremic syndrome associated with complement c3 mutation. Case Rep Nephrol. 2014;2014:784943. http://dx.doi.org/10.1155/2014/784943

2.Kavanagh D, Goodship TH, Richards A. Atypical haemolytic uraemic syndrome. Br Med Bull. 2006;77-78:5-22.

3.Yenerel MN. Atypical Hemolytic Uremic Syndrome: differential diagnosis from TTP/HUS and management. Turk J Haematol. 2014;31(3):216-25. http://dx.doi.org/10.4274/tjh.2013.0374

4.Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012;8(11):622-33. http://dx.doi.org/10.1038/nrneph.2012.195

5.Proesmans W. Typical and atypical hemolytic uremic syndrome. Kidney Blood Press Res. 1996;19(3-4):205-8. http://dx.doi.org/10.1159/000174075

6.Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001;60(3):831-46. http://dx.doi.org/10.1046/j.1523-1755.2001.060003831.x

7.Christmann M, Hansen M, Bergmann C, Schwabe D, Brand J, Schneider W. Eculizumab as first-line therapy for atypical hemolytic uremic syndrome. Pediatrics. 2014;133(6):e1759-63. http://dx.doi.org/10.1542/peds.2013-1787

8.Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368(23):2169-81. http://dx.doi.org/10.1056/nejmoa1208981

9. Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL. Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012; 38(08):845-853. http://dx.doi.org/10.1055/s-0032-1328894

10.Pavlovsky M, Weinstein R. Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: prospective observations of an emerging syndrome. J Clin Apher. 1997;12(4):159-64. http://dx.doi.org/10.1002/(sici)1098-1101(1997)12:4<159::aid-jca1>3.3.co;2-p

11.Jubelirer SJ, Ratliff HL, Cotes DJ, Riley MA, Welch CA. Thrombotic Throbmocytopenic Purpura (TTP) following Coronary Artery Bypass: Case series and review of the literature. WV Medical Journal. 2015;111(1):10- 14.

12. Kavanagh D, Goodship T, Richards A. Atypical hemolytic uremic syndrome. Seminars in Nephrology. 2013;33(6):508-530. http://dx.doi.org/10.1016/j.semnephrol.2013.08.003

13. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(17):1676-1687. http://dx.doi.org/10.1056/nejmra0902814

14. Kavanagh D, Goodship T. Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations. Hematology Am Soc Hematol Educ Program. 2011:15-20. http://dx.doi.org/10.1182/asheducation-2011.1.15

Share

COinS